Xylanase variants and polynucleotides encoding same
AssigneeNovozymes A/S
InventorsSteffen Danielsen, Peter Kamp Hansen, Frank Winther Rasmussen, Roland Alexander Pache
Life of this patent
Estimating the term…
Abstract
The present invention relates to xylanase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; compositions comprising the xylanase variants and methods of using the variants.
Claims29
A xylanase variant, comprising a substitution at a position corresponding to position 74 of SEQ ID NO:
- 1, wherein the xylanase variant has xylanase activity and wherein the xylanase variant has at least 97% and less than 100% sequence identity to SEQ ID NO:
- 1, 2, 3, 4, 5 and/or 6.
A liquid formulation comprising the xylanase variant of claim 1 and 20-80% w/w of polyol.
A xylanase variant, comprising a substitution at a position corresponding to position 74 of SEQ ID NO:
- 1 with leucine, wherein the xylanase variant has xylanase activity and wherein the xylanase variant has at least 90% and less than 100% sequence identity to SEQ ID NO:
- 1, 2, 3, 4, 5 and/or 6.
A liquid formulation comprising the xylanase variant of claim 16 and 20-80% w/w of polyol.
Dependencies are inferred from the claim text.